EN | UA
EN | UA

Help Support

Back

Efficacy of various elimination schemes for H. pylori infection in pediatrics

H. pylori H. pylori
H. pylori H. pylori

The purpose of a single-center prospective study was to assess the efficacy of three eradication regimens against H. pylori infection in children.

See All

Key take away

As a first-line therapeutic option in pediatrics, triple therapy with Metronidazole + Proton pump inhibitor + Amoxicillin for 14 days can attain a higher H. pylori elimination rate.

Background

The purpose of a single-center prospective study was to assess the efficacy of three eradication regimens against H. pylori infection in children.

Method

H. pylori-infected children aged 6 to 17 years were recruited. Volunteers were randomly allocated to receive either sequential treatment, Clarithromycin therapy (CLR), or Metronidazole (MTZ) therapy. By analyzing faecal antigen, the efficacy of the eradication therapy was assessed 4–8 weeks following therapy cessation.

Result

A total of 149 patients were included over an 18-month period. The eradication rate and side effects reported in proton pump inhibitor (PPI) + Amoxicillin (AMO) + MTZ, PPI + AMO + CLR, and sequential therapy, are shown in Figure 1:

MTZ therapy but not sequential therapy was superior to CLR therapy.

Conclusion

As a first-line therapy, MTZ-based therapy has the potential to effectively eradicate H. pylori.

Source:

Children

Article:

The Effectiveness of Different Eradication Schemes for Pediatric Helicobacter pylori Infection—A Single-Center Comparative Study from Romania

Authors:

Oana-Maria Rosu et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: